D61.1 Drug-induced aplastic anemiaBillable ICD-10-CM code, FY2026. Acts as a Major Complication or Comorbidity (MCC) as a secondary diagnosis.
Defines the logic of DRG(s) 808-810 in MDC 16.
284.89 Other specified aplastic anemias (approximate)D46 Myelodysplastic syndromes ("drug-induced aplastic anemia (D61.1)")D61.810 Antineoplastic chemotherapy induced pancytopenia ("aplastic anemia due to antineoplastic chemotherapy (D61.1)")D61.811 Other drug-induced pancytopenia ("aplastic anemia due to drugs (D61.1)")D63.0 Anemia in neoplastic disease ("aplastic anemia due to antineoplastic chemotherapy (D61.1)")D64.81 Anemia due to antineoplastic chemotherapy ("aplastic anemia due to antineoplastic chemotherapy (D61.1)")M90.5 Osteonecrosis in diseases classified elsewhere ("hemoglobinopathy (D50-D64)")R71 Abnormality of red blood cells ("anemias (D50-D64)")D61.0 Constitutional aplastic anemiaD61.01 Constitutional (pure) red blood cell aplasiaD61.02 Shwachman-Diamond syndromeD61.03 Fanconi anemiaD61.09 Other constitutional aplastic anemiaD61.1 Drug-induced aplastic anemia (this code)D61.2 Aplastic anemia due to other external agentsD61.3 Idiopathic aplastic anemiaD61.8 Other specified aplastic anemias and other bone marrow failure syndromesD61.81 PancytopeniaD61.810 Antineoplastic chemotherapy induced pancytopenia